Skip to content

Lung Cancer Blog

Everything about lung cancer is here.

Menu
  • Home
  • About Us
  • Lung Cancer
    • Lung Cancer News
    • Causes of Lung Cancer
    • Lung Cancer Symptoms
    • Types of Lung Cancer
    • Stages of Lung Cancer
    • Lung Cancer Treatment
    • Lung Cancer Drugs
    • Lung Cancer In Ayurveda
    • Chinese Herbs For Lung Cancer
  • Researches
  • Studies
  • Stories
  • Sitemap
  • Contact Us
Menu
lung | Lung Cancer

New Test Oracle To Predict Survival in Early-Stage Lung Cancer

Posted on January 13, 2025
Post Views: 497

lung | Lung CancerResearchers at the Francis Crick Institute and University College London Cancer Institute have demonstrated that ORACLE test can better predict clinical outcomes for patients with early-stage lung cancer in comparison with other methods. These findings have been published in Nature Cancer. This could allow doctors to identify patients with early-stage lung cancer that would benefit from chemotherapy and surgery.

ORACLE was initially developed in the year 2019 and was tested on 158 people with lung cancer. Unlike other testing methods which capture only a small fraction of tumor, ORACLE analyzes the genes expressed across all tumor regions. Also, the team examined 359 lung cancer drugs to determine their potential efficacy. It was found that ORACLE showed promising results in predicting chemotherapy response. It opens up the possibility of using ORACLE to guide specific treatments as a monitoring tool.

According to Dhruva Biswas, MD, PhD, a visiting scientist at the Crick and co-first author of the study, “ORACLE can predict survival rates in patients diagnosed at the earliest stage.” Doctors could use ORACLE to make more informed decisions regarding lung cancer treatment and get better insights about the cancer.

In ORACLE test, a tumor sample is taken via biopsy and then it is analyzed in the presence of a specific set of 23 genes. It looks at how strongly each of these genes are expressed in the tumor and then a numerical risk score is generated. This score represents the risk of tumor spread.

The success of ORACLE in evaluating early-stage lung cancer helps researchers to compare the survival outcomes of patients with high ORACLE scores in comparison to those who undergo closer chemotherapy. This will help in improving survival even in those diagnosed at the earliest stage. The need for better markers is on the rise to accurately classify tumors and predict those who are at high risk.

The information shared in this blog is for educational purposes only.

Subscribe to our newsletter or follow us on Facebook or Twitter today to stay informed and never miss an update!

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Tumblr (Opens in new window) Tumblr
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Telegram (Opens in new window) Telegram

Like this:

Like Loading...

Subscribe Us

Popular Articles

  • Lung Cancer Treatment in Ayurveda (7,322)
  • Lung Cancer: Symptoms and Treatment (5,655)
  • What is Non-Small-Cell Lung Cancer? (5,551)

Recent Comments

  • Lung Cancer on New Study To Help Advance Research In Lung Cancer
  • Laurie B Grimes on New Study To Help Advance Research In Lung Cancer
  • Lung Cancer on Asbestos and Lung Cancer – What’s The Link?

Recent Articles

  • Study: Wildfire Smoke Exposure Affects Lung Cancer Survival June 2, 2025
  • Predicting Lung Cancer Risk with AI based Deep Learning Model May 26, 2025
  • FDA Grants Accelerated Approval to Telisotuzumab Vedotin-tllv for NSCLC May 19, 2025
  • Heart-Sparing Technique in Lung Cancer Radiotherapy May 12, 2025
  • Origins of Common Lung Cancer Linked to Smoking Discovered May 5, 2025

Lung Cancer Blog

Lung Cancer Blog provides all lung cancer related information for educational purposes.

Disclaimer

Some post may contain affiliate links, purchasing that product not going to cost extra but by your purchase Lung Cancer will get some little commission and that amount will help in surviving this website. So, please don’t hesitate to buy from these affiliate links.

Contact Us

If you have any query or suggestions about our blog, please feel free to email us at  lungcancersymptomsx@gmail.com.

Copyright © 2012 - 2025 Lung Cancer Blog. Wordpress by Vipasha.
  • Privacy Policy
  • About Us
  • Sitemap
  • Contact Us
%d